Renaissance Technologies - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 279 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$3,133
+41.3%
130,800
+11.0%
0.01%
+66.7%
Q1 2023$2,217
-55.9%
117,800
-62.7%
0.00%
-57.1%
Q4 2022$5,026
-99.2%
315,700
+737.4%
0.01%
+600.0%
Q3 2022$617,000
+75.8%
37,700
+160.0%
0.00%
Q1 2022$351,000
-97.7%
14,500
-97.5%
0.00%
-100.0%
Q1 2021$14,990,000
+53.7%
581,000
+218.5%
0.02%
+72.7%
Q4 2020$9,751,000
-12.3%
182,400
-32.3%
0.01%0.0%
Q3 2020$11,117,000
+104.4%
269,500
+140.2%
0.01%
+120.0%
Q2 2020$5,438,000
+111.7%
112,200
+84.5%
0.01%
+150.0%
Q1 2020$2,569,000
-91.8%
60,800
-91.7%
0.00%
-91.7%
Q4 2019$31,272,000
+912.7%
731,000
+752.0%
0.02%
+700.0%
Q3 2019$3,088,000
-68.1%
85,800
-85.6%
0.00%
-72.7%
Q4 2018$9,666,000
+170.2%
597,800
+247.0%
0.01%
+175.0%
Q3 2018$3,577,000
+5.0%
172,300
-22.8%
0.00%
+100.0%
Q2 2018$3,408,000223,2000.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders